KIMYRSA

oritavancin diphosphate · Melinta Therapeutics, LLC

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for KIMYRSA, covering 2021-03-12 to 2025-04-24. Get the full timeline:

Most recent: FDA Approved: KIMYRSA — Supplemental Application (Melinta Therapeutics, LLC)